Ajanta Pharma Ltd Board Meeting Scheduled for May 5, 2026, to Approve Annual and Quarterly Financial Results
Ajanta Pharma Ltd has announced that its Board of Directors meeting is scheduled for Tuesday, May 5, 2026. The meeting is set to review and approve critical financial documentation for the company.During the meeting, the board will consider and approve the audited financial results for the quarter and the full year ended March 31, 2026. The approval process covers both consolidated and standalone results. Furthermore, the board will approve the comprehensive audited financial statements for the year ending March 31, 2026, which are available in both consolidated and standalone formats.
AJANTPHARM Stock Price Movement
Today, Ajanta Pharma Limited shares edged higher to close at ₹2791.2, gaining 0.59% on the day. The equity saw significant trading activity, completing the session with a total volume of 138,603 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.